Angioedema most often affects the lips, eyes, tongue, throat, arms, and legs. It is the swelling of the lower layer of tissue ...

They can last for hours, weeks, or even years. Angioedema is different. The swelling happens under the skin, not on the surface. It’s marked by deep swelling around the eyes and lips and ...

BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present at the ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that it will present new sebetralstat data at two upcoming ...

The FDA has accepted the New Drug Application for berotralstat as prophylactic therapy for pediatric patients aged 2 to 11 years with hereditary angioedema.

The US Food and Drug Administration (FDA) has accepted BioCryst Pharmaceuticals’ new drug application (NDA) for Orladeyo.

Hereditary angioedema (HAE) is a potentially life-threatening genetic disorder characterized by recurrent swelling attacks.

A new study highlights age, allergies, smoking, and history of angioedema as non-genetic risk factors for ACEi/ARB-induced ...

Twenty-year old Noah Davis-Logan is a former national medalist in track, college student, and dedicated advocate for ...

has accepted for Priority Review the New Drug Application for berotralstat as prophylactic therapy for pediatric patients aged 2 to 11 years with hereditary angioedema (HAE). In the trial ...